Pyrimidine-2,4,6-triones are a new class of voltage-gated L-type Ca2+ channel activators - Wikidata - awgldk - TriplyDB

Pyrimidine-2,4,6-triones are a new class of voltage-gated L-type Ca2+ channel activators

Pyrimidine-2,4,6-triones are a new class of voltage-gated L-type Ca2+ channel activators

http://www.wikidata.org/entity/Q33851635

about

The Physiology, Pathology, and Pharmacology of Voltage-Gated Calcium Channels and Their Future Therapeutic Potential Converging roles of ion channels, calcium, metabolic stress, and activity pattern of Substantia nigra dopaminergic neurons in health and Parkinson's disease L-type calcium channels as drug targets in CNS disorders CACNA1D de novo mutations in autism spectrum disorders activate Cav1.3 L-type calcium channels Post-transcriptional modifications and "Calmodulation" of voltage-gated calcium channel function: Reflections by two collaborators of David T Yue Regulation of aldosterone secretion by Cav1.3.Splice variants of the CaV1.3 L-type calcium channel regulate dendritic spine morphology.Pharmacology of L-type Calcium Channels: Novel Drugs for Old Targets?Cav1.3 Channels as Key Regulators of Neuron-Like Firings and Catecholamine Release in Chromaffin Cells.Regulation of Postsynaptic Stability by the L-type Calcium Channel CaV1.3 and its Interaction with PDZ Proteins Targeting voltage-gated calcium channels in neurological and psychiatric diseases.A Polybasic Plasma Membrane Binding Motif in the I-II Linker Stabilizes Voltage-gated CaV1.2 Calcium Channel Function.Cav 1.3 channels play a crucial role in the formation of paroxysmal depolarization shifts in cultured hippocampal neurons.Calcium signalling through L-type calcium channels: role in pathophysiology of spinal nociceptive transmission.Binding mechanisms of 1,4-dihydropyridine derivatives to L-type calcium channel Cav1.2: a molecular modeling study.New gain-of-function mutation shows CACNA1D as recurrently mutated gene in autism spectrum disorders and epilepsy.Mechanisms Responsible for ω-Pore Currents in Cav Calcium Channel Voltage-Sensing Domains.

P2860

Q26781422-0A21E863-ECD4-4EDE-A2DB-BAF0CF85911B Q28074143-21140E23-42AD-4F1C-A38E-0F91D4CEAEDE Q28081812-EA0C68BD-DDC9-425E-8BBC-B4478C998704 Q35461678-4F7AED8E-B693-48A4-A933-B61EA718C95B Q36714856-AD173167-C5F5-4A6F-AE69-C97FB17C2889 Q36926861-A29F037D-A501-4973-A8B7-1ECF85579043 Q37314745-61D64730-CAFB-4C85-8ED8-DEBF6E0601E9 Q38475657-EDEC47E5-D4BA-443D-A9D9-5AC2E1437943 Q38475669-B63652BD-C654-4494-BE47-5A25F35EA2CE Q38475692-C3E5309B-FB51-42DA-AB30-C284402E639B Q38626606-8324E192-4885-43EC-8CBF-06FA1A6EA6F3 Q38861018-1437D23D-82C8-4A76-9D5B-A3DEF296F95F Q38907067-44FF621F-D032-4C11-BF3A-D2407F5314A1 Q39141992-D4C3AE69-97FD-4EAF-8AE6-016682BB3FA8 Q40206445-975D71F9-F47E-4880-8584-25DF4528B1B5 Q42428358-0C69E718-EB81-4C22-9C98-D25DB4499F0C Q47131974-D5086652-D82A-4A57-9062-9C919FE04C23

P2860

Pyrimidine-2,4,6-triones are a new class of voltage-gated L-type Ca2+ channel activators

http://www.wikidata.org/entity/Q33851635

description

2014 nî lūn-bûn

@nan

2014 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Pyrimidine-2,4,6-triones are a new class of voltage-gated L-type Ca2+ channel activators

@ast

Pyrimidine-2,4,6-triones are a new class of voltage-gated L-type Ca2+ channel activators

@en

type

label

Pyrimidine-2,4,6-triones are a new class of voltage-gated L-type Ca2+ channel activators

@ast

Pyrimidine-2,4,6-triones are a new class of voltage-gated L-type Ca2+ channel activators

@en

prefLabel

Pyrimidine-2,4,6-triones are a new class of voltage-gated L-type Ca2+ channel activators

@ast

Pyrimidine-2,4,6-triones are a new class of voltage-gated L-type Ca2+ channel activators

@en

P1433

Q33851635-A886F9DD-2669-4592-8380-E38960BE0D0B

P1476

Q33851635-D5903873-9E4E-47C9-B984-DCE5F4183FF4

P2093

Q33851635-4DDD631B-0210-433F-A932-55A55D83A48E

Q33851635-60EB9835-CC39-43B3-9E28-295022291D3D

Q33851635-9F5F3AF4-A1C6-4D18-AFE9-5B41E285987E

Q33851635-B8101FA1-F0DD-4E2A-B5A1-681D1D0744F7

Q33851635-FC7617B7-CF6A-4571-A7CF-43C4707032D9

P2860

Q33851635-00532021-C621-49A5-BE04-576A02BFEC2B

Q33851635-03360BFC-FF0A-4127-9DD0-EAD4FC14663F

Q33851635-18CE2ADC-561D-4C3D-A834-BB9265E27CC4

Q33851635-192DE976-237A-477C-803F-8A49BEF09F2A

Q33851635-1A1D12B4-058F-43D4-B9E7-4707AF56F73F

Q33851635-255AD08E-E961-415F-A6A3-1A49C260349C

Q33851635-2A351B0A-E40C-4C3F-9AF0-B7E4EE4E2189

Q33851635-2B0C9442-8FF7-4D0E-AD4A-7321FFAC39E6

Q33851635-2CB18844-D98A-4F50-932D-44CDDAA65D7F

Q33851635-2D4331D1-BED6-4220-A386-3014FE236A2E

P2888

Q33851635-2EEC30C7-52DB-4E1E-A2B4-EE499C1D6B0E

P304

Q33851635-8CC8933C-1511-467C-A69B-AF88912E94AF

P31

Q33851635-A23B8BC2-FCAA-4CA0-A556-DB7030AFC692

P356

Q33851635-04FCD5C6-3D7F-4052-A721-8820635B9DE2

P407

Q33851635-892DAF11-D2ED-4403-AAE3-9F0931E88485

P478

Q33851635-B3221448-0C8E-439F-B144-F960540AFB7F

P50

Q33851635-339FA5EF-0E5D-46CC-9F2E-8B309308B3DF

Q33851635-850A7E93-5898-4BCA-9C2F-A2B9F2A00353

Q33851635-9C2CC3DF-AB6F-43C0-8394-41285AA8DA6D

Q33851635-EBB378BB-161B-4A8B-A4CB-F92568B3F31C

P577

Q33851635-9EF2C743-311D-4104-9FEF-2B772CDA156C

P5875

Q33851635-1E009797-C2A5-4B84-A22E-3D2B335DBFC5

P6179

Q33851635-C56157E3-0613-4FC5-B7E3-0E7D09A13D57

P698

Q33851635-E2185A1F-85A6-4B1B-B00C-67DCE843AA6F

P932

Q33851635-235EE0BF-18E5-43FC-A55A-B09FB0221360

P356

P1433

Nature Communications

P1476

Pyrimidine-2,4,6-triones are a new class of voltage-gated L-type Ca2+ channel activators

@en

P2093

David H F Vandael

http://www.w3.org/2001/XMLSchema#string

Gabriella Bock

http://www.w3.org/2001/XMLSchema#string

Henning J Draheim

http://www.w3.org/2001/XMLSchema#string

Robert Mauersberger

http://www.w3.org/2001/XMLSchema#string

Ronald Gust

http://www.w3.org/2001/XMLSchema#string

P2860

Biophysical properties, pharmacology, and modulation of human, neuronal L-type (alpha(1D), Ca(V)1.3) voltage-dependent calcium currents

The bipolar disorder risk allele at CACNA1C also confers risk of recurrent major depression and of schizophrenia

International Union of Pharmacology. XLVIII. Nomenclature and structure-function relationships of voltage-gated calcium channels

'Rejuvenation' protects neurons in mouse models of Parkinson's disease

Neuronal Ca(V)1.3alpha(1) L-type channels activate at relatively hyperpolarized membrane potentials and are incompletely inhibited by dihydropyridines

Robust pacemaking in substantia nigra dopaminergic neurons.

L-type calcium channel blockers and Parkinson disease in Denmark.

Isoform-specific regulation of mood behavior and pancreatic beta cell and cardiovascular function by L-type Ca 2+ channels

Sites of proteolytic processing and noncovalent association of the distal C-terminal domain of CaV1.1 channels in skeletal muscle

FPL 64176 modification of Ca(V)1.2 L-type calcium channels: dissociation of effects on ionic current and gating current.

P2888

P304

3897

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/NCOMMS4897

http://www.w3.org/2001/XMLSchema#string

P407

P478

5

http://www.w3.org/2001/XMLSchema#string

P50

Joerg Striessnig

Nadine J Ortner

P577

2014-06-19T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

263290941

http://www.w3.org/2001/XMLSchema#string

P6179

1044329621

http://www.w3.org/2001/XMLSchema#string

P698

24941892

http://www.w3.org/2001/XMLSchema#string

P932

4083433

http://www.w3.org/2001/XMLSchema#string